Kubo S, Ariga T, Tsuneta H, Ishii T
Department of Paediatrics, Hokkaido Central Hospital for Social Health Insurance, Sapporo, Japan.
Eur J Pediatr. 1991 May;150(7):507-8. doi: 10.1007/BF01958434.
A male neonate with hyperbilirubinaemia and progressing anaemia due to rhesus (c + E) incompatibility received high dose intravenous gammaglobulin (ivIgG) therapy at 13 days of age. Clinical response to therapy was confirmed by a rapid decrease in serum bilirubin level, and with the prevention of a further decline of the haemoglobin level. No side-effects were noted. High dose ivIgG therapy could be an alternative to (exchange) blood transfusion in case of some haemolytic diseases of newborn.
一名因恒河猴血型（c + E）不相容而患有高胆红素血症并伴有进行性贫血的男婴在13日龄时接受了高剂量静脉注射丙种球蛋白（ivIgG）治疗。血清胆红素水平迅速下降以及血红蛋白水平进一步下降得到预防，证实了治疗的临床反应。未观察到副作用。对于某些新生儿溶血病，高剂量ivIgG治疗可能是（换血）输血的替代方法。
